Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Greenlight Capital, led by David Einhorn, has disclosed its Q2 2025 13F filing trades.
Oruka Therapeutics, Inc. ("Oruka") (NASDAQ:ORKA), a biotechnology company developing novel biologics designed to set a ...
ARCA biopharma updates the previously announced final amount of the special cash dividend (the "Special Dividend"), whi...
ARCA biopharma, Inc. (NASDAQ:ABIO) ("ARCA") today announced that its Board of Directors (the "Board") has appro...
ARCA Biopharma shares are trading higher by 8.1% Monday morning. The company announced a special dividend of $1.59 per share.
Special dividend estimated to be $1.59 per share Payment of special dividend conditioned upon ARCA stockholder approval of the ...
